|
Volumn 22, Issue 4, 1996, Pages 265-287
|
Use of bisphosphonates in cancer patients
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALENDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
CALCITONIN;
CALCIUM;
CLODRONIC ACID;
CORTICOSTEROID;
ETIDRONIC ACID;
FUROSEMIDE;
IBANDRONIC ACID;
LORON;
MITHRAMYCIN;
PAMIDRONIC ACID;
PREDNISONE;
UNCLASSIFIED DRUG;
ZOLEDRONIC ACID;
APOPTOSIS;
BONE MARROW TOXICITY;
BONE METASTASIS;
BONE PAIN;
BREAST CANCER;
CALCIUM BLOOD LEVEL;
CANCER;
CANCER INVASION;
CANCER PATIENT;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG CYTOTOXICITY;
DRUG MECHANISM;
DRUG USE;
FEVER;
FLU LIKE SYNDROME;
HUMAN;
HYPERCALCEMIA;
HYPOCALCEMIA;
HYPOPHOSPHATEMIA;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER TOXICITY;
MULTIPLE MYELOMA;
NEPHROTOXICITY;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
OSTEOCLAST;
OSTEOLYSIS;
PROSTATE CANCER;
REVIEW;
SALURESIS;
|
EID: 0030479201
PISSN: 03057372
EISSN: None
Source Type: Journal
DOI: 10.1016/S0305-7372(96)90020-1 Document Type: Article |
Times cited : (95)
|
References (97)
|